Atlas Trials

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria

Clinical trial NCT07241234 · RECRUITING

Trial details

NCT number
NCT07241234
Sponsor
Agios Pharmaceuticals, Inc.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Phenylketonuria
Start date
2026-04-17
Primary completion
2028-01-17
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.